Th9 cells promote antitumor immune responses in vivo
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Th9 cells are a subset of CD4+ Th cells that produce the pleiotropic cytokine IL-9. IL-9/Th9 can function as both positive and negative regulators of immune response, but the role of IL-9/Th9 in tumor immunity is unknown. We examined the role of IL-9/Th9 in a model of pulmonary melanoma in mice. Lack of IL-9 enhanced tumor growth, while tumor-specific Th9 cell treatment promoted stronger antitumor responses in both prophylactic and therapeutic models. Th9 cells also elicited strong host antitumor CD8+ CTL responses by promoting Ccl20/Ccr6-dependent recruitment of DCs to the tumor tissues. Subsequent tumor antigen delivery to the draining LN resulted in CD8+ T cell priming. In agreement with this model, Ccr6 deficiency abrogated the Th9 cell-mediated antitumor response. Our data suggest a distinct role for tumor-specific Th9 cells in provoking CD8+ CTL-mediated antitumor immunity and indicate that Th9 cell-based cancer immunotherapy may be a promising therapeutic approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-9 has been shown to favour CD8 T-cell activation in a model of pulmonary melanoma in mice36.”
From Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells (2017) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“This observation is in contrast to previous findings demonstrating a role of Th9 cells in controlling anti-tumour immune responses in solid tumours such as melanomas.26,27”
From PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells (2022) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., & Stockinger, B. (2008) · Nature Immunology · doi:10.1038/ni.1659 · Cited by 1,213
Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M., Strom, T. B., Elyaman, W., Ho, I.-C., et al. (2008) · Nature Immunology · doi:10.1038/ni.1677 · Cited by 1,122
Maldonado-López, R., De Smedt, T., Michel, P., Godfroid, J., Pajak, B., Heirman, C., Thielemans, K., Leo, O., Urbain, J., & Moser, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.587 · Cited by 984
Tumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 845
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 842
Self-citationT Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N. P., Overwijk, W. W., & Dong, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.014 · Cited by 800
Helping the CD8+ T-cell response
Bevan, M. J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1413 · Cited by 797
Cited by
Items 101–200 of 382
Xue, G., Wang, Z., Zheng, N., Fang, J., Mao, C., Li, X., Jin, G., Ming, X., & Lu, Y. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00799-6 · Cited by 52
Self-citationUSP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity
Hong, B., Li, H., Lu, Y., Zhang, M., Zheng, Y., Qian, J., & Yi, Q. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-132 · Cited by 53
Self-citationT-Cell Immunity in Pancreatic Cancer
Ajina, R., & Weiner, L. M. (2020) · Pancreas · doi:10.1097/mpa.0000000000001621 · Cited by 50
Neglected, yet significant role of FOXP1 in T-cell quiescence, differentiation and exhaustion
Kaminskiy, Y., Kuznetsova, V., Kudriaeva, A. A., Zmievskaya, E., & Bulatov, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.971045 · Cited by 49
Maywald, M., Wang, F., & Rink, L. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.02.004 · Cited by 44
The Role of Chemoattractant Receptors in Shaping the Tumor Microenvironment
Zhou, J., Xiang, Y., Yoshimura, T., Chen, K., Gong, W., Huang, J., Zhou, Y., Yao, X., Bian, X., & Wang, J. (2014) · BioMed Research International · doi:10.1155/2014/751392 · Cited by 46
Rampal, R., Awasthi, A., & Ahuja, V. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3vma1015-476r · Cited by 48
PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity
Daenthanasanmak, A., Wu, Y., Iamsawat, S., Nguyen, H. D., Bastian, D. A., Zhang, M.-M., Sofi, M. H., Chatterjee, S., Hill, E. G., Mehrotra, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95407 · Cited by 45
Heim, L., Chiriac, M. T., Kachler, K., Mitsch, S., 杨祖钦, Koelle, J., Kharwadkar, R., Geppert, C.-I., Tausche, P., Hohenberger, K., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2022.859738 · Cited by 45
Dendritic cells treated with chloroquine modulate experimental autoimmune encephalomyelitis
Thomé, R., Issayama, L. K., Gangi, R. D., Bombeiro, A. L., da Costa, T. A., Ferreira, I. T., de Oliveira, A. L. R., & Verinaud, L. M. C. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.73 · Cited by 46
Carrascosa, L. C., Klein, M., Kitagawa, Y., Lückel, C., Marini, F., König, A., Guralnik, A., Raifer, H., Hagner-Benes, S., Raedler, D., et al. (2017) · Nature Communications · doi:10.1038/ncomms15366 · Cited by 44
Transcriptional Control of Th9 Cells: Role of Foxo1 in Interleukin-9 Induction
Malik, S., & Awasthi, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00995 · Cited by 42
IL-9 Exerts Antitumor Effects in Colon Cancer and Transforms the Tumor Microenvironment In Vivo
Wang, J., Sun, M., Zhao, H., Huang, Y., Li, D., Mao, D., Zhang, Z., Zhu, X., Dong, X., & Zhao, X. (2019) · Technology in Cancer Research & Treatment · doi:10.1177/1533033819857737 · Cited by 43
Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9
Fu, Y., Pajulas, A., Wang, J., Zhou, B., Cannon, A., Cheung, C. C. L., Zhang, J., Zhou, H., Fisher, A. J., Omstead, D. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31596-7 · Cited by 42
Pajulas, A., Zhang, J., & Kaplan, M. H. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300094 · Cited by 43
Differentiation, Regulation and Function of Th9 Cells
Jia, L., & Wu, C. Y. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-9487-9_7 · Cited by 57
Helper-like innate lymphoid cells and cancer immunotherapy
Crinier, A., Vivier, É., & Bléry, M. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.04.002 · Cited by 41
Parrot, T., Allard, M., Oger, R., Benlalam, H., de la Blétière, D. R., Coutolleau, A., Preisser, L., Desfrançois, J., Khammari, A., Dréno, B., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201546061 · Cited by 42
Harnessing the IL-21-BATF Pathway in the CD8+ T Cell Anti-Tumor Response
Topchyan, P., Xin, G., Chen, Y., Zheng, S., Burns, R., Shen, J., Kasmani, M. Y., Kudek, M. R., Yang, N., & Cui, W. (2021) · Cancers · doi:10.3390/cancers13061263 · Cited by 43
Distinct interferon‐gamma and interleukin‐9 expression in cutaneous and oral lichen planus
Weber, B., Schlapbach, C., Stuck, M., Simon, H., Borradori, L., Beltraminelli, H., & Simon, D. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13989 · Cited by 41
Qi, C., Shan, Y., Wang, J., Ding, F., Zhao, D., Yang, T. C., & Jiang, Y. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12567 · Cited by 41
Immunopathogenesis of inflammatory bowel diseases: functional role of T cells and T cell homing.
Zundler, S., & Neurath, M. F. (2015) · PubMed · Cited by 51
Singh, Y., Garden, O. A., Lang, F., & Cobb, B. S. (2016) · Immunology · doi:10.1111/imm.12631 · Cited by 37
Therapeutic potential of interleukin-21 in cancer
Isvoranu, G., & Chiritoiu‐Butnaru, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1369743 · Cited by 37
A reappraisal of IL-9 in inflammation and cancer
Bick, F., Blanchetot, C., Lambrecht, B. N., & Schuijs, M. J. (2024) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.10.003 · Cited by 37
Chemokine-Driven CD4 + T Cell Homing: New Concepts and Recent Advances
Whyte, C. E., Foeng, J., Comerford, I., & McColl, S. R. (2017) · Advances in immunology · doi:10.1016/bs.ai.2017.03.001 · Cited by 43
Transcriptional Programs Underlying Cd4 T Cell Differentiation and Functions
Chalmin, F., Humblin, É., Ghiringhelli, F., & Végran, F. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.07.002 · Cited by 35
Li, N., Xie, Q., Chen, Q., Evivie, S. E., Liu, D., Dong, J., Huo, G., & Li, B. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c06039 · Cited by 35
Immune modulation in malignant pleural effusion: from microenvironment to therapeutic implications
Ge, S., Zhao, Y., Liang, J., He, Z., Li, K., Zhang, G., Hua, B., Zheng, H., Guo, Q., Qi, R., et al. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03211-w · Cited by 35
ATP Triggers Human Th9 Cell Differentiation via Nitric Oxide-Mediated mTOR-HIF1α Pathway
Roy, S., & Awasthi, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01120 · Cited by 33
Regulatory roles of MicroRNA in shaping T cell function, differentiation and polarization
Naqvi, R. A., Datta, M., Khan, S. H., & Naqvi, A. R. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.08.003 · Cited by 35
Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus
Silva, R. C. M. C., Lopes, M. F., & Travassos, L. H. (2022) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2022.11.001 · Cited by 33
Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis
Ohtsuki, S., Wang, C., Watanabe, R., Zhang, H., Akiyama, M., Bois, M. C., Maleszewski, J. J., Warrington, K. J., Berry, G. J., Goronzy, J. J., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101012 · Cited by 33
Yao, X., Kong, Q., Xie, X., Wang, J., Li, N., Liu, Y., Sun, B., Li, Y., Wang, G., Li, W., et al. (2014) · Immunology · doi:10.1111/imm.12322 · Cited by 32
Self-citationGM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses
Kim, I., Koh, C., Jeon, I., Shin, K., Kang, T.-S., Bae, E., Seo, H., Ko, H., Kim, B., Chung, Y., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0518 · Cited by 35
Perez, S. A., Anastasopoulou, E. A., Tzonis, P., Gouttefangeas, C., Kalbacher, H., Papamichail, M., & Baxevanis, C. N. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1461-3 · Cited by 31
Association between low expression levels of interleukin-9 and colon cancer progression
Huang, Y., Cao, Y., Zhang, S., & Gao, F. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2588 · Cited by 31
BFAR coordinates TGFβ signaling to modulate Th9-mediated cancer immunotherapy
Pei, S., Huang, M., Huang, J., Zhu, X., Wang, H., Romano, S., Deng, X., Wang, Y., Luo, Y., Hao, S., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202144 · Cited by 33
Self-citationShen, L., Xiao, Y., Tian, J., & Lu, Z. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.01.006 · Cited by 31
Li, Y., Yu, Q., Zhang, Z., Wang, J., Li, S., Zhang, J., & Liu, G. (2016) · Oncotarget · doi:10.18632/oncotarget.11681 · Cited by 34
Kumar, S., Dhamija, B., Marathe, S., Ghosh, S., Dwivedi, A., Karulkar, A., Sharma, N., Sengar, M., Epari, S., Bonda, A., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0894 · Cited by 31
Amazing IL-9: revealing a new function for an “old” cytokine
Schmitt, E., & Bopp, T. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65929 · Cited by 31
Kumar, S., Chan, C. J., & Coussens, L. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.17002-x · Cited by 37
Sex chromosome loss and the pseudoautosomal region genes in hematological malignancies
Weng, S., Stoner, S. A., & Zhang, D. (2016) · Oncotarget · doi:10.18632/oncotarget.12050 · Cited by 31
Discovery and initial characterization of Th9 cells: the early years
Schmitt, E., & Bopp, T. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0610-0 · Cited by 31
Host dysbiosis negatively impacts IL-9-producing T-cell differentiation and antitumour immunity
Almeida, R. R., Vieira, R. D. S., Castoldi, Â., Terra, F. F., de Melo, A. C. L., Canesso, M. C. C., Lemos, L., Cipelli, M., Rana, N., Hiyane, M. I., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0915-6 · Cited by 28
The Complex Dysregulations of CD4 T Cell Subtypes in HIV Infection
Tolomeo, M., & Cascio, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147512 · Cited by 35
IL-9 Expression by Invariant NKT Cells Is Not Imprinted during Thymic Development
Monteiro, M., Agua‐Doce, A., Almeida, C. F., Fonseca‐Pereira, D., Veiga‐Fernandes, H., & Graça, L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403170 · Cited by 30
STAT3 Activation Impairs the Stability of Th9 Cells
Ulrich, B. J., Verdan, F. F., McKenzie, A. N. J., Kaplan, M. H., & Olson, M. R. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601624 · Cited by 29
IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production
Yoshimura, S., Thomé, R., Konno, S., Mari, E. R., Rasouli, J., Hwang, D., Boehm, A., Lǐ, Y., Zhang, G., Ćirić, B., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1801113 · Cited by 29
Zhang, J., Wang, W.-D., Geng, Q.-R., Wang, L., Chen, X.-Q., Liu, C.-C., & Lv, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094637 · Cited by 27
Self-citationT cell cytokine signatures: Biomarkers in pediatric multiple sclerosis
Cala, C. M., Moseley, C. E., Steele, C. H., Dowdy, S. M., Cutter, G., Ness, J., & DeSilva, T. M. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.04.015 · Cited by 27
Kato, D., Yaguchi, T., Iwata, T., Morii, K., Nakagawa, T., Nishimura, R., & Kawakami, Y. (2017) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.40.68 · Cited by 28
Benevides, L., Sesti‐Costa, R., Tavares, L. A., Russo, M., Martins, G. A., daSilva, L. L. P., Arruda, L. K., Cunha, F. Q., Carregaro, V., & Silva, J. S. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.06.046 · Cited by 31
Park, S.-A., Lim, Y.-J., Ku, W. L., Zhang, D., Cui, K., Tang, L.-Y., Chia, C., Zanvit, P., Chen, Z., Jin, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33733-8 · Cited by 26
Self-citationFu, J., Heinrichs, J. L., & Yu, X. (2014) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-014-0284-z · Cited by 28
Gerlach, K., Popp, V., Wirtz, S., Al-Saifi, R., Gonzalez Acera, M., Atreya, R., Dregelies, T., Vieth, M., Fichtner-Feigl, S., McKenzie, A. N. J., et al. (2022) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjac097 · Cited by 25
STAT5 Represses a STAT3-Independent Th17-like Program during Th9 Cell Differentiation
Canaria, D. A., Yan, B., Clare, M. G., Zhang, Z., Taylor, G. A., Boone, D. L., Kazemian, M., & Olson, M. R. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100165 · Cited by 25
Differentiation and regulation of CD4+ T cell subsets in Parkinson’s disease
Sun, X., Gu, R., & Bai, J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05402-0 · Cited by 27
Nakajima, T., Kanno, T., Ueda, Y., Miyako, K., Endo, T., Yoshida, S., Yokoyama, S., Asou, H. K., Yamada, K., Ikeda, K., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01209-y · Cited by 27
Hoppenot, D., Malakauskas, K., Lavinskienė, S., & Sakalauskas, R. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0119-7 · Cited by 31
Interleukin-9 Inhibits Lung Metastasis of Melanoma through Stimulating Anti-Tumor M1 Macrophages.
Park, S. M., Do-Thi, V. A., Lee, J., Lee, H., & Kim, Y. S. (2020) · PubMed Central · doi:10.14348/molcells.2020.0047 · Cited by 27
Skin tumor immunity: Site does matter for antigen presentation by DCs
Waithman, J. C., Gebhardt, T., & Bedoui, S. (2016) · European Journal of Immunology · doi:10.1002/eji.201646293 · Cited by 24
The Role of Interleukin-9 in Cancer
Lee, J. E., Zhu, Z., Bai, Q., Brady, T. M., Xiao, H., Wakefield, M. R., & Fang, Y. (2019) · Pathology & Oncology Research · doi:10.1007/s12253-019-00665-6 · Cited by 25
Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in Cancer
Saillard, M., Cenerenti, M., Romero, P., & Jandus, C. (2021) · Vaccines · doi:10.3390/vaccines9050454 · Cited by 23
Joulia, E., Michieletto, M. F., Agesta, A., Peillex, C., Girault, V., Dorze, A.-L. L., Peroceschi, R., Bucciarelli, F., Szelechowski, M., Chaubet, A., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230449 · Cited by 25
Cutting Edge: AhR Is a Molecular Target of Calcitriol in Human T Cells
Takami, M., Fujimaki, K., Nishimura, M. I., & Iwashima, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500344 · Cited by 24
Utilizing TH9 cells as a novel therapeutic strategy for malignancies
Lu, Y., & Yi, Q. (2013) · OncoImmunology · doi:10.4161/onci.23084 · Cited by 24
Self-citationFeatures and roles of T helper 9 cells and interleukin 9 in immunological diseases
Yazdani, R., Shapoori, S., Rezaeepoor, M., Sanaei, R., Ganjalıkhani-Hakemi, M., Azizi, G., Rae, W. M., Aghamohammadi, A., & Rezaei, N. (2018) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2018.02.003 · Cited by 27
Castelli, S., Wilson, W. V., Uslu, U., Finck, A., Rommel, P. C., Assenmacher, C., Atoche, S. J., Siurala, M., Aznar, M. A., Young, R. M., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.10.021 · Cited by 24
Wu, S., Dai, X., Xia, Y., Zhao, Q., Heng, Z., Shi, Z., Yin, X., Liu, X., Zhang, A., Yao, Z., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114111 · Cited by 22
Potential Mechanisms of T Cell-Mediated and Eosinophil-Independent Bronchial Hyperresponsiveness
Saeki, M., Nishimura, T., Kitamura, N., Hiroi, T., Mori, A., & Kaminuma, O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122980 · Cited by 23
Feng, B., Pan, B., Huang, J., Du, Y., Wang, X., Wu, J., Ma, R., Shen, B., Huang, G., & Feng, J. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216224 · Cited by 23
Dectin-1-activated dendritic cells: A potent Th9 cell inducer for tumor immunotherapy
Chen, J., Zhao, Y., Chu, X., Lu, Y., Wang, S., & Yi, Q. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1238558 · Cited by 21
Self-citationInnate lymphoid cells: A potential link between microbiota and immune responses against cancer
Panda, S. K., & Colonna, M. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.03.003 · Cited by 23
IL-9 and Th9 Cells in Tumor Immunity
He, Y., Lin, D., Cao, Y., Bi, Y., & Liu, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38315-2_3 · Cited by 23
Li, N., Xie, Q., Zhao, L., Shi, J., Evivie, S. E., Lv, X., Huo, G., & Li, B. (2021) · Food & Function · doi:10.1039/d0fo03004j · Cited by 21
Das, S., Srinivasan, S., Srivastava, A., Kumar, S., Das, G., Das, S., Dwivedi, A., Karulkar, A., Makkad, K., Bilala, R., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800823 · Cited by 23
Alkaline Cytosolic pH and High Sodium Hydrogen Exchanger 1 (NHE1) Activity in Th9 Cells
Singh, Y., Zhou, Y., Shi, X., Zhang, S., Umbach, A. T., Salker, M. S., Lang, K. S., & Lang, F. J. W. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.730259 · Cited by 21
Protein Phosphatase 2A: Role in T Cells and Diseases
Roy, S., & Batra, L. (2023) · Journal of Immunology Research · doi:10.1155/2023/4522053 · Cited by 21
Treating tumors with immune checkpoint inhibitors: Rationale and limitations
Seidel, J. A., Otsuka, A., & Kabashima, K. (2017) · Trends in Immunotherapy · doi:10.24294/ti.v1.i1.20 · Cited by 20
Th9 Cells: Probable players in ulcerative colitis pathogenesis
Shohan, M., Elahi, S., Shirzad, H., Rafieian‐Kopaei, M., Bagheri, N., & Soltani, E. (2018) · International Reviews of Immunology · doi:10.1080/08830185.2018.1457659 · Cited by 22
Zhang, Y., Siegel, A., Sun, G., DiMaggio, T., Freeman, A. F., & Milner, J. D. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.06.036 · Cited by 22
T Helper Cell Subsets in Experimental Lung Allograft Rejection
Yamada, Y., Bruestle, K., & Jungraithmayr, W. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.07.073 · Cited by 20
Cellular metabolism in Th9, Th17, and Treg cell differentiation
Kanno, T., Nakano, K., & Endo, Y. (2025) · International Immunology · doi:10.1093/intimm/dxaf032 · Cited by 21
Ye, J., Chen, L., Waltermire, J., Zhao, J., Ren, J., Guo, Z. S., Bartlett, D. L., & Liu, Z. (2024) · Cancers · doi:10.3390/cancers16051021 · Cited by 18
Self-citationDo-Thi, V. A., Park, S. M., Lee, H., & Kim, Y. S. (2018) · Immune Network · doi:10.4110/in.2018.18.e12 · Cited by 18
Th9 cytokines curb cervical cancer progression and immune evasion
Chauhan, S. R., Singhal, P. G., Sharma, U., Bandil, K., Chakraborty, K., & Bharadwaj, M. (2019) · Human Immunology · doi:10.1016/j.humimm.2019.09.009 · Cited by 20
Tong, H., Feng, H., Hu, X., Wang, M., Song, Y., Wen, X., Li, Y., & Wan, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.544248 · Cited by 18
Paracrine IL-2 Is Required for Optimal Type 2 Effector Cytokine Production
Olson, M. R., Ulrich, B. J., Hummel, S. A., Khan, I., Meuris, B., Cherukuri, Y., Dent, A. L., Janga, S. C., & Kaplan, M. H. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601792 · Cited by 18
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies
Salas‐Benito, D., Berger, T. R., & Maus, M. V. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-012235 · Cited by 18
Silver, R. F., Xia, M., Storer, C. E., Jarvela, J. R., Moyer, M., Blazevic, A., Stoeckel, D. A., Rakey, E. K., Tennant, J. M., Goll, J. B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-44136-8 · Cited by 19
Liu, H., Zhang, Y., Liu, Z., Wang, P., Mo, X., Fu, W., Liu, W., Cheng, Y., & Han, W. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1292195 · Cited by 17
Self-citationInterleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia
Patrussi, L., Capitani, N., & Baldari, C. T. (2021) · Cancers · doi:10.3390/cancers13246301 · Cited by 18
Feng, Y., Yan, S., Lam, S. K., Ko, F. C. F., Chen, C., Khan, M., & Ho, J. (2022) · Lung Cancer · doi:10.1016/j.lungcan.2022.10.002 · Cited by 16
Masuda, J., Takayama, E., Strober, W., Satoh, A., Morimoto, Y., Honjo, Y., Ichinohe, T., Tokuno, S., Ishizuka, T., Nakata, T., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5646 · Cited by 17
Ding, P., Zhu, R., Cai, B., Zhang, J., Bu, Q., & Sun, D. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105576 · Cited by 16
Janus or Hydra: The Many Faces of T Helper Cells in the Human Tumour Microenvironment
Guisier, F., Barros‐Filho, M. C., Rock, L. D., Strachan-Whaley, M. R., Marshall, E. A., Dellaire, G., & Lam, W. L. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35723-8_3 · Cited by 18
Fang, H., Li, R., Gu, Y., Fei, Y., Jin, K., Chen, Y., Cao, Y., Liu, X., Lv, K., Wang, J., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1856468 · Cited by 18
Self-citationAnticancer Tc9 cells: Long-lived tumor-killing T cells for adoptive therapy
Lu, Y., Wang, Q., & Yi, Q. (2014) · OncoImmunology · doi:10.4161/onci.28542 · Cited by 17
Self-citation
Metadata
- Authors
- Lu, Y., Hong, S., Li, H., Park, J., Hong, B., Wang, L., Zheng, Y., Liu, Z., Xu, J., He, J., Yang, J., Qian, J., & Yi, Q.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Yi, Qing
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-15
- Volume
- 122
- Issue
- 11
- Pages
- 4160-4171
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3484462
- OpenAlex
- W2066906123
- Cited by
- 361
- References
- 50
- Citations by year
- 2026: 13 · 2025: 22 · 2024: 19 · 2023: 25 · 2022: 27 · 2021: 24 · 2020: 33 · 2019: 37 · 2018: 35 · 2017: 34 · 2016: 34 · 2015: 26 · 2014: 18 · 2013: 13 · 2012: 1
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Multiple Myeloma Research Foundation
- Commonwealth Foundation
- Leukemia and Lymphoma Society
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (R01CA138402, R01CA138398, R01CA163881, P50CA142509, P30CA016672)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- Th9 cells, IL-9, antitumor immunity, pulmonary melanoma, CD8+ cytotoxic T lymphocytes, dendritic cell recruitment, tumor antigen delivery, draining lymph nodes, cancer immunotherapy, CD4+ T cells
- MeSH terms
- Animals, Dendritic Cells, T-Lymphocytes, Helper-Inducer, Immunity, Cellular, Immunotherapy, Lung Neoplasms, Melanoma, Interleukin-9, Antigen Presentation, Mice, Knockout, CD8-Positive T-Lymphocytes, Cell Line, Tumor, Mice, Receptors, CCR6, Chemokine CCL20
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.